Find out about a study of a live attenuated intranasal pertussis vaccine, including the findings compared with current pertussis vaccines.

Read about the roles of the U.S. federal, state and local governments in implementing vaccine policy and find four areas where individuals can affect change.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced the launch of the initial phase of DISCOVERY of Risk Factors for Type 2 Diabetes in Youth, a nationwide National Institute of Health (NIH) study to address the surge in youth diagnosed with type 2 diabetes over the past two decades.

Children’s Hospital of Philadelphia (CHOP) announced that five of its physicians and researchers were among the ninety-eight new members selected to join the American Pediatric Society (APS), one of North America's first and most prestigious academic pediatric organizations.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy trial for Danon disease (DD), a rare, X-linked heart condition caused by a single gene mutation. The data on the results of the RP-A501 Phase 1 trial, presented at a late breaking session today at the American Heart Association Scientific Sessions 2024 in Chicago, were also published in the New England Journal of Medicine.

Yael Mossé, MD, received the William Osler Patient Oriented Research Award, which was established in 1996 to honor Osler, a “Father of Clinical Medicine” who, in the 1800s, revolutionized clinical teaching and patient-oriented research at the Perelman School of Medicine at the University of Pennsylvania.

Family Newsletter from the Comprehensive Hemostasis and Thrombosis Center at Children’s Hospital of Philadelphia.

Children’s Hospital of Philadelphia announced today that it has earned the 2025 Military Friendly ® Employer designation. This is the fifth year in a row that CHOP has received the distinction.

Study found statistically significant benefit when health workers made efforts to coordinate asthma care between homes, schools and primary care providers

Made possible with a $4 million grant from the Brazilian Ministry of Health, CHOP cell therapy specialists will offer their expertise and resources to oversee this initiative.